Translumbar inferior vena cava catheters

W. D. Haire, R. P. Lieberman, G. B. Lund, Margaret Anne Kessinger

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Translumbar inferior vena cava catheters are a safe method of providing venous access for the collection of peripheral blood stem cells for transplantation. One of the most frequent and consistent problems with these catheters is thrombotic obstruction, occurring in one-fourth of the cases. Aspirin at a dose of 325 mg daily beginning after catheter placement and continuing until completion of stem cell collection has been associated with a reduction in the frequency of catheter thrombosis from 12/60 (20%) to 1/31 (3.2%) (p = 0.007) and an increase in the number of thrombus-free apheresis procedures (p = 0.024) compared to historical controls. No adverse effects of aspirin during stem cell collection have been noted. Daily aspirin ingestion should be considered in patients undergoing peripheral stem cell collection via translumbar inferior vena cava catheters.

Original languageEnglish (US)
Pages (from-to)389-392
Number of pages4
JournalBone marrow transplantation
Volume7
Issue number5
StatePublished - Jan 1 1991

Fingerprint

Inferior Vena Cava
Catheters
Aspirin
Thrombosis
Stem Cells
Peripheral Blood Stem Cell Transplantation
Blood Component Removal
Eating

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Haire, W. D., Lieberman, R. P., Lund, G. B., & Kessinger, M. A. (1991). Translumbar inferior vena cava catheters. Bone marrow transplantation, 7(5), 389-392.

Translumbar inferior vena cava catheters. / Haire, W. D.; Lieberman, R. P.; Lund, G. B.; Kessinger, Margaret Anne.

In: Bone marrow transplantation, Vol. 7, No. 5, 01.01.1991, p. 389-392.

Research output: Contribution to journalArticle

Haire, WD, Lieberman, RP, Lund, GB & Kessinger, MA 1991, 'Translumbar inferior vena cava catheters', Bone marrow transplantation, vol. 7, no. 5, pp. 389-392.
Haire WD, Lieberman RP, Lund GB, Kessinger MA. Translumbar inferior vena cava catheters. Bone marrow transplantation. 1991 Jan 1;7(5):389-392.
Haire, W. D. ; Lieberman, R. P. ; Lund, G. B. ; Kessinger, Margaret Anne. / Translumbar inferior vena cava catheters. In: Bone marrow transplantation. 1991 ; Vol. 7, No. 5. pp. 389-392.
@article{2afafc04c5ca45589f55d4140d309b39,
title = "Translumbar inferior vena cava catheters",
abstract = "Translumbar inferior vena cava catheters are a safe method of providing venous access for the collection of peripheral blood stem cells for transplantation. One of the most frequent and consistent problems with these catheters is thrombotic obstruction, occurring in one-fourth of the cases. Aspirin at a dose of 325 mg daily beginning after catheter placement and continuing until completion of stem cell collection has been associated with a reduction in the frequency of catheter thrombosis from 12/60 (20{\%}) to 1/31 (3.2{\%}) (p = 0.007) and an increase in the number of thrombus-free apheresis procedures (p = 0.024) compared to historical controls. No adverse effects of aspirin during stem cell collection have been noted. Daily aspirin ingestion should be considered in patients undergoing peripheral stem cell collection via translumbar inferior vena cava catheters.",
author = "Haire, {W. D.} and Lieberman, {R. P.} and Lund, {G. B.} and Kessinger, {Margaret Anne}",
year = "1991",
month = "1",
day = "1",
language = "English (US)",
volume = "7",
pages = "389--392",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Translumbar inferior vena cava catheters

AU - Haire, W. D.

AU - Lieberman, R. P.

AU - Lund, G. B.

AU - Kessinger, Margaret Anne

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Translumbar inferior vena cava catheters are a safe method of providing venous access for the collection of peripheral blood stem cells for transplantation. One of the most frequent and consistent problems with these catheters is thrombotic obstruction, occurring in one-fourth of the cases. Aspirin at a dose of 325 mg daily beginning after catheter placement and continuing until completion of stem cell collection has been associated with a reduction in the frequency of catheter thrombosis from 12/60 (20%) to 1/31 (3.2%) (p = 0.007) and an increase in the number of thrombus-free apheresis procedures (p = 0.024) compared to historical controls. No adverse effects of aspirin during stem cell collection have been noted. Daily aspirin ingestion should be considered in patients undergoing peripheral stem cell collection via translumbar inferior vena cava catheters.

AB - Translumbar inferior vena cava catheters are a safe method of providing venous access for the collection of peripheral blood stem cells for transplantation. One of the most frequent and consistent problems with these catheters is thrombotic obstruction, occurring in one-fourth of the cases. Aspirin at a dose of 325 mg daily beginning after catheter placement and continuing until completion of stem cell collection has been associated with a reduction in the frequency of catheter thrombosis from 12/60 (20%) to 1/31 (3.2%) (p = 0.007) and an increase in the number of thrombus-free apheresis procedures (p = 0.024) compared to historical controls. No adverse effects of aspirin during stem cell collection have been noted. Daily aspirin ingestion should be considered in patients undergoing peripheral stem cell collection via translumbar inferior vena cava catheters.

UR - http://www.scopus.com/inward/record.url?scp=0025863050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025863050&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 389

EP - 392

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 5

ER -